Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.
This guidance has been updated to include a review of the cost model using more recent values. New evidence and updated costs identified during the guidance review are denoted as .
NICE guidance states that this is for use in a community setting, this being primary care. OPCS-4 is only mandated for use in secondary care in the admitted patient care dataset. As this would be carried out by a nurse in community setting no OPCS-4 code would be assigned. Unless this is being considered for inpatients, the patients would need to be admitted under a consultant in order that and FCE to be generated OPCS-4 code assigned.